Home › Germ Cell and Embryonal Cancer › New York
Pag-aaral pangklinika para sa Germ Cell and Embryonal Cancer sa New York
6 pag-aaral para sa Germ Cell and Embryonal Cancer ang naghahanap ng mga kalahok sa mga site sa New York.
Mga Lungsod sa New York
Opisyal na teksto ng pag-aaral (English)
A Study of ZW251 in Participants With Advanced Solid Tumors
- Memorial Sloan Kettering Cancer Center, New York
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT07164313Accelerated v's Standard BEP Chemotherapy for Patients With Intermediate and Poor-risk Metastatic Germ Cell Tumours
- Memorial Sloan Kettering Cancer Centre, New York
Nagre-recruitPhase 3
Edad 11 hanggang 50 · Lahat ng kasarian · Na-update Set 1, 2026 · NCT02582697Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors
- Albany Medical Center, Albany
- Maimonides Medical Center, Brooklyn
- Roswell Park Cancer Institute, Buffalo
- at 13 pa
Nagre-recruitPhase 3
Lahat ng edad · Lahat ng kasarian · Na-update Ago 25, 2026 · NCT03067181Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors
- Icahn School of Medicine at Mount Sinai, New York
- Montefiore Einstein Comprehensive Cancer Center, The Bronx
Nagre-recruitPhase 1
Edad 15 pataas · Lahat ng kasarian · Na-update Ago 25, 2026 · NCT06276491Vorinostat in Combination With Chemotherapy in Relapsed/Refractory Solid Tumors and CNS Malignancies
- New York Medical College, Valhalla
Nagre-recruitPhase 1
Edad 1 hanggang 30 · Lahat ng kasarian · Na-update Abr 15, 2026 · NCT04308330Germ Cell Tumor and Testicular Tumor DNA Registry
- Cold Springs Harbor Laboratory (Specimen Analysis), Cold Spring Harbor
- Memorial Sloan Kettering Commack, Commack
- Memorial Sloan Kettering Westchester, Harrison
- at 2 pa
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 18 pataas · Lahat ng kasarian · Na-update Peb 4, 2026 · NCT02099734Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.